Sandy Preiss

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter

Filter by Year

Search Results

Evaluation of text cluster naming with generative large language models

Effect of Paxlovid treatment during Acute COVID-19 on long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia

Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID

Evaluating policies to decrease the risk of introducing SARS-CoV-2 infections to nursing home facilities

Estimate of undetected severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in acute-care hospital settings using an individual-based microsimulation model

Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program

Dug: A semantic search engine leveraging peer-reviewed knowledge to query biomedical data repositories

Using named entity recognition to identify substances used in the self-medication of opioid withdrawal: Natural language processing study of Reddit data

Incorporation of near-real-time hospital occupancy data to improve hospitalization forecast accuracy during the COVID-19 pandemic

Can social media monitoring help identify the next EVALI? An examination of Reddit posts about vitamin E acetate and Dank Vapes

Lessons learned from the rapid development of a statewide simulation model for predicting COVID-19’s impact on healthcare resources and capacity

Estimating the effective reproduction number of COVID-19 in North Carolina

Increases in naloxone administrations by emergency medical services providers during the COVID-19 pandemic: Retrospective time-series study

Intersectoral cooperation to increase HPV vaccine coverage: An innovative collaboration between managed care organizations and state-level stakeholders

Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?

Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers